SCHEDULE: Rosalind Advisors Discloses 9.9% Stake in PolyPid Ltd.

Rosalind Advisors Inc. and related entities have filed a Schedule 13G, reporting a 9.9% beneficial ownership in PolyPid Ltd., with significant holdings subject to blocker provisions.

Summary

• Rosalind Advisors Inc., Rosalind Master Fund L.P., Steven Salamon, and Gilad Aharon have jointly filed a Schedule 13G, indicating beneficial ownership of 9.9% of PolyPid Ltd.'s common shares.
• The total reported beneficial ownership is 5,124,011 shares, with 565,655 shares directly held and 4,558,356 shares issuable upon exercise of warrants.
• A 'blocker' provision limits the exercise of warrants, preventing beneficial ownership from exceeding 9.99% of the common stock, meaning these shares are not currently exercisable.
• The filing is based on 19,174,078 ordinary shares outstanding as of March 31, 2026, as per a PolyPid Ltd. 6-K filing on May 13, 2026.
• Rosalind Advisors Inc. acts as the investment advisor to Rosalind Master Fund L.P., and Steven Salamon is the portfolio manager for Rosalind Advisors Inc.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing as neutral to slightly negative, primarily due to the disclosure of a significant stake that is subject to 'blocker' provisions, limiting immediate control and potentially signaling a cautious or strategic approach rather than outright bullishness.

Positives

• Disclosure of a significant stake (9.9%) in PolyPid Ltd. by a known investment advisor and fund.
• The filing indicates a structured approach to investment, with clear roles defined for the advisor and fund.

Negatives

• A substantial portion of the reported ownership (4,558,356 shares) is tied to warrants that are currently unexercisable due to 'blocker' provisions, limiting immediate influence or control.
• The effective direct ownership (565,655 shares) is significantly lower than the total reported beneficial ownership, suggesting a strategic, rather than fully committed, position.

Risks

• The 'blocker' provision on warrants means that the reported 9.9% ownership is not fully realized and could be subject to future adjustments or limitations.
• The inability to exercise warrants due to exceeding the 9.99% ownership threshold could indicate potential regulatory concerns or a deliberate strategy to avoid triggering stricter disclosure or control requirements.

Future Outlook

The filing does not contain specific forward-looking statements or guidance from PolyPid Ltd. The outlook is primarily related to the reporting persons' investment strategy concerning their stake in the company, which is currently constrained by warrant blocker provisions.

Management Comments

• Rosalind Advisors Inc. is the investment advisor to RMF and may be deemed to be the beneficial owner of shares held by RMF.
• Steven Salamon is the portfolio manager of the Advisor and may be deemed to be the beneficial owner of shares held by RMF.
• The Advisor and Mr. Salamon disclaim beneficial ownership of the shares held by RMF.
• The securities reported show the number of shares that would be issuable upon full conversion and exercise of such reported securities and do not give effect to such blockers.
• The actual number of shares beneficially owned, after giving effect to such blockers, is less than the number of securities reported.

Industry Context

StockSavvy.ai notes that Schedule 13G filings typically indicate passive investment stakes. The presence of 'blocker' provisions on warrants, as seen here, is a common mechanism for large investors to acquire potential upside without triggering control implications or exceeding regulatory ownership thresholds, often seen in biotechnology or growth-stage companies like PolyPid Ltd.

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by Rosalind Advisors may signal increased institutional interest, but the unexercisable warrants limit immediate impact on control or voting power.
• Management of PolyPid Ltd.: The filing confirms a substantial passive investor, which could influence future strategic discussions or board composition if the stake were to become more active.

Next Steps

• The reporting persons will continue to monitor their investment in PolyPid Ltd.
• Future actions may depend on the performance of PolyPid Ltd. and the potential removal or adjustment of warrant blocker provisions.

Key Dates

Keywords

PolyPid Ltd., Schedule 13G, Rosalind Advisors, Rosalind Master Fund, Steven Salamon, Gilad Aharon, Beneficial Ownership, Warrants